Robin K Kelley1. Show Affiliations » 1. University of California, San Francisco, San Francisco, CA.
Abstract
Entities: Chemical Disease
Mesh: See more » Alanine/analogs & derivativesAlanine/therapeutic useAntineoplastic Combined Chemotherapy Protocols/therapeutic useCarcinoma, Hepatocellular/drug therapyDrug Resistance, Neoplasm/drug effectsFemaleHumansLiver Neoplasms/drug therapyMaleNiacinamide/adverse effectsNiacinamide/analogs & derivativesNiacinamide/therapeutic usePalliative CarePhenylurea Compounds/adverse effectsPhenylurea Compounds/therapeutic useProtein Kinase Inhibitors/adverse effectsProtein Kinase Inhibitors/therapeutic useSalvage TherapySorafenibTriazines/therapeutic use
Substances: See more » Phenylurea CompoundsProtein Kinase InhibitorsTriazinesNiacinamideSorafenibbrivanibAlanine
Year: 2013 PMID: 23980088 DOI: 10.1200/JCO.2013.49.7941
Source DB: PubMed Journal: J Clin Oncol ISSN: 0732-183X Impact factor: 44.544